Abstract:Advanced MaterialsVolume 23, Issue 12 p. H84-H89 Communication “Advanced Healthcare Materials” RGD-Modified PEG-PAMAM-DOX Conjugate: In Vitro and In Vivo Targeting to Both Tumor Neovascular Endothelial Cells and Tumor Cells Saijie Zhu, Saijie Zhu Department of Pharmaceutics, Key Laboratory of Smart Drug Delivery, Ministry of Education and PLA School of Pharmacy, Fudan University, 826 Zhangheng Road, 201203 Shanghai, P. R. ChinaSearch for more papers by this authorLili Qian, Lili Qian Department of Pharmaceutics, Key Laboratory of Smart Drug Delivery, Ministry of Education and PLA School of Pharmacy, Fudan University, 826 Zhangheng Road, 201203 Shanghai, P. R. ChinaSearch for more papers by this authorMinghuang Hong, Minghuang Hong Department of Pharmaceutics, Key Laboratory of Smart Drug Delivery, Ministry of Education and PLA School of Pharmacy, Fudan University, 826 Zhangheng Road, 201203 Shanghai, P. R. ChinaSearch for more papers by this authorLihong Zhang, Lihong Zhang Department of Pharmaceutics, Key Laboratory of Smart Drug Delivery, Ministry of Education and PLA School of Pharmacy, Fudan University, 826 Zhangheng Road, 201203 Shanghai, P. R. ChinaSearch for more papers by this authorYuanying Pei, Yuanying Pei Department of Pharmaceutics, Key Laboratory of Smart Drug Delivery, Ministry of Education and PLA School of Pharmacy, Fudan University, 826 Zhangheng Road, 201203 Shanghai, P. R. ChinaSearch for more papers by this authorYanyan Jiang, Corresponding Author Yanyan Jiang [email protected] Department of Pharmaceutics, Key Laboratory of Smart Drug Delivery, Ministry of Education and PLA School of Pharmacy, Fudan University, 826 Zhangheng Road, 201203 Shanghai, P. R. ChinaDepartment of Pharmaceutics, Key Laboratory of Smart Drug Delivery, Ministry of Education and PLA School of Pharmacy, Fudan University, 826 Zhangheng Road, 201203 Shanghai, P. R. China.Search for more papers by this author Saijie Zhu, Saijie Zhu Department of Pharmaceutics, Key Laboratory of Smart Drug Delivery, Ministry of Education and PLA School of Pharmacy, Fudan University, 826 Zhangheng Road, 201203 Shanghai, P. R. ChinaSearch for more papers by this authorLili Qian, Lili Qian Department of Pharmaceutics, Key Laboratory of Smart Drug Delivery, Ministry of Education and PLA School of Pharmacy, Fudan University, 826 Zhangheng Road, 201203 Shanghai, P. R. ChinaSearch for more papers by this authorMinghuang Hong, Minghuang Hong Department of Pharmaceutics, Key Laboratory of Smart Drug Delivery, Ministry of Education and PLA School of Pharmacy, Fudan University, 826 Zhangheng Road, 201203 Shanghai, P. R. ChinaSearch for more papers by this authorLihong Zhang, Lihong Zhang Department of Pharmaceutics, Key Laboratory of Smart Drug Delivery, Ministry of Education and PLA School of Pharmacy, Fudan University, 826 Zhangheng Road, 201203 Shanghai, P. R. ChinaSearch for more papers by this authorYuanying Pei, Yuanying Pei Department of Pharmaceutics, Key Laboratory of Smart Drug Delivery, Ministry of Education and PLA School of Pharmacy, Fudan University, 826 Zhangheng Road, 201203 Shanghai, P. R. ChinaSearch for more papers by this authorYanyan Jiang, Corresponding Author Yanyan Jiang [email protected] Department of Pharmaceutics, Key Laboratory of Smart Drug Delivery, Ministry of Education and PLA School of Pharmacy, Fudan University, 826 Zhangheng Road, 201203 Shanghai, P. R. ChinaDepartment of Pharmaceutics, Key Laboratory of Smart Drug Delivery, Ministry of Education and PLA School of Pharmacy, Fudan University, 826 Zhangheng Road, 201203 Shanghai, P. R. China.Search for more papers by this author First published: 01 March 2011 https://doi.org/10.1002/adma.201003944Citations: 109Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat Graphical Abstract A novel multifunctional drug–polymer conjugate is prepared. RGD peptide is used to actively target the drug delivery system to tumor neovascular endothelial cells and tumor cells, while the PEG-PAMAM polymeric carrier permits passive targeting to the tumor site by the enhanced permeability and retention (EPR) effect. Controlled release of the anticancer drug doxorubicin is also achieved via acid-sensitive cis-aconityl linkage. Supporting Information Detailed facts of importance to specialist readers are published as ”Supporting Information”. Such documents are peer-reviewed, but not copy-edited or typeset. They are made available as submitted by the authors. Filename Description adma_201003944_sm_suppl.pdf851 KB suppl Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article. References 1 W. Cai, G. Niu, X. Chen, Curr. Pharm. Des. 2008, 14, 2943. 10.2174/138161208786404308 CASPubMedWeb of Science®Google Scholar 2 K. Temming, R. M. Schiffelers, G. Molema, R. J. Kok, Drug Resist. Updates 2005, 8, 381. 10.1016/j.drup.2005.10.002 CASPubMedWeb of Science®Google Scholar 3 M. P. Borgman, O. Aras, S. Geyser-Stoops, E. A. Sausville, H. Ghandehari, Mol. Pharmaceutics 2009, 6, 1836. 10.1021/mp900134c CASPubMedWeb of Science®Google Scholar 4 M. Oba, K. Aoyagi, K. Miyata, Y. Matsumoto, K. Itaka, N. Nishiyama, Y. Yamasaki, H. Koyama, K. Kataoka, Mol. Pharmaceutics 2008, 5, 1080. 10.1021/mp800070s CASPubMedWeb of Science®Google Scholar 5 Z. Liu, S. Liu, G. Niu, F. Wang, S. Liu, X. Chen, Mol. Imaging 2010, 9, 21. CASPubMedWeb of Science®Google Scholar 6 S. Zhu, M. Hong, L. Zhang, G. Tang, Y. Jiang, Y. Pei, Pharm. Res. 2010, 27, 161. 10.1007/s11095-009-9992-1 CASPubMedWeb of Science®Google Scholar 7 S. Zhu, M. Hong, G. Tang, L. Qian, J. Lin, Y. Jiang, Y. Pei, Biomaterials 2010, 31, 1360. 10.1016/j.biomaterials.2009.10.044 CASPubMedWeb of Science®Google Scholar 8 D. B. Leeper, K. Engin, A. J. Thistlethwaite, H. D. Hitchon, J. D. Dover, D. J. Li, L. Tupchong, Int. J. Radiat. Oncol. Biol. Phys. 1994, 28, 935. 10.1016/0360-3016(94)90114-7 CASPubMedWeb of Science®Google Scholar 9 A. S. E. Ojugo, P. M. J. McSheehy, D. J. O. McIntyre, C. McCoy, M. Stubbs, M. O. Leach, I. R. Judson, J. R. Griffiths, NMR Biomed. 1999, 12, 495. 10.1002/(SICI)1099-1492(199912)12:8<495::AID-NBM594>3.0.CO;2-K CASPubMedWeb of Science®Google Scholar 10 R. van Sluis, Z. M. Bhujwalla, N. Raghunand, P. Ballesteros, J. Alvarez, S. Cerdán, J. P. Galons, R. J. Gillies, Magn. Reson. Med. 1999, 41, 743. 10.1002/(SICI)1522-2594(199904)41:4<743::AID-MRM13>3.0.CO;2-Z CASPubMedWeb of Science®Google Scholar 11 J. Liu, J. I. Shapiro, Biol. Res. Nurs. 2003 , 5, 117. 10.1177/1099800403256860 PubMedGoogle Scholar 12 J. Z. Du, T. M. Sun, W. J. Song, J. Wu, J. Wang, Angew. Chem. Int. Ed. 2010, 49, 3621. 10.1002/anie.200907210 CASPubMedWeb of Science®Google Scholar 13 R. Kluger, C. H. Lam, J. Am. Chem. Soc. 1978, 100, 2191. 10.1021/ja00475a033 CASWeb of Science®Google Scholar 14 D. Q. McNerny, J. F. Kukowska-Latallo, D. G. Mullen, J. M. Wallace, A. M. Desai, R. Shukla, B. Huang, M. M. Banaszak Holl, J. R. Baker, Bioconjugate Chem. 2009, 20, 1853. 10.1021/bc900217h CASPubMedWeb of Science®Google Scholar 15 W. Lu, Q. Sun, J. Wan, Z. She, X. G. Jiang, Cancer Res. 2006, 66, 11878. 10.1158/0008-5472.CAN-06-2354 CASPubMedWeb of Science®Google Scholar 16 N. Nasongkla, X. Shuai, H. Ai, B. D. Weinberg, J. Pink, D. A. Boothman, J. Gao, Angew. Chem. Int. Ed. 2004, 43, 6323. 10.1002/anie.200460800 CASPubMedWeb of Science®Google Scholar 17 R. M. Schiffelers, G. A. Koning, T. L. ten Hagen, M. H. Fens, A. J. Schraa, A. P. Janssen, P. J. Kok, G. Molema, G. Storm, J. Controlled Release 2003, 91, 115. 10.1016/S0168-3659(03)00240-2 CASPubMedWeb of Science®Google Scholar 18 A. K. Singh, B. S. Kasinath, E. J. Lewis. Biochim. Biophys. Acta 1992, 1120, 337. 10.1016/0167-4838(92)90257-E CASPubMedWeb of Science®Google Scholar 19 O. P. Perumal, R. Inapagolla, S. Kannan, R. M. Kannan, Biomaterials 2008, 29, 3469. 10.1016/j.biomaterials.2008.04.038 CASPubMedWeb of Science®Google Scholar 20 M. Hong, S. Zhu, Y. Jiang, G. Tang, Y. Pei, J. Controlled Release 2009, 133, 96. 10.1016/j.jconrel.2008.09.005 CASPubMedWeb of Science®Google Scholar 21 N. Kamaly, T. Kalber, M. Thanou, J. D. Bell, A. D. Miller, Bioconjugate Chem. 2009, 20, 648. 10.1021/bc8002259 CASPubMedWeb of Science®Google Scholar 22 S. Samanta, R. Sistla, A. Chaudhuri, Biomaterials 2010, 31, 1787. 10.1016/j.biomaterials.2009.10.027 CASPubMedWeb of Science®Google Scholar 23 D. H. Yu, Q. Lu, J. Xie, C. Fang, H. Z. Chen, Biomaterials 2010, 31, 2278. 10.1016/j.biomaterials.2009.11.047 CASPubMedWeb of Science®Google Scholar 24 Q. Cao, Z. Li, K Chen, Z. Wu, L. He, N. Neamati, X. Chen, Eur. J. Nucl. Med. Mol. Imaging 2008, 35, 1489. 10.1007/s00259-008-0744-y CASPubMedWeb of Science®Google Scholar 25 A. Nanda, B. St Croix, Curr. Opin. Oncol. 2004, 16, 44. 10.1097/00001622-200401000-00009 CASPubMedWeb of Science®Google Scholar 26 R. Tomlinson, J. Heller, S. Brocchini, R. Duncan, Bioconjugate Chem. 2003, 14, 1096. 10.1021/bc030028a CASPubMedWeb of Science®Google Scholar 27 X. B. Xiong, Y. Huang, W. L. Lu, X. Zhang, H. Zhang, T. Nagai, Q. Zhang, J. Controlled Release 2005, 107, 262. 10.1016/j.jconrel.2005.03.030 CASPubMedWeb of Science®Google Scholar Citing Literature Volume23, Issue12March 25, 2011Pages H84-H89 ReferencesRelatedInformation

Abstract:NanomedicineVol. 6, No. 4 EditorialCopolymer technology for advanced nanomedicineZhiping Zhang, Xiangliang Yang & Si-Shen FengZhiping ZhangTongji School of Pharmacy, Huazhong University of Science & Technology, Wuhan 430030, China and National Engineering Research Center for Nanomedicine, Huazhong University of Science & Technology, Wuhan 430074, ChinaSearch for more papers by this author, Xiangliang YangCollege of Life Science & Technology and National Engineering Research Center for Nanomedicine, Huazhong University of Science & Technology, Wuhan 430074, ChinaSearch for more papers by this author & Si-Shen Feng† Author for correspondenceDepartment of Chemical & Biomolecular Engineering and Department of Bioengineering, National University of Singapore, Singapore 117576, Singapore. Search for more papers by this authorEmail the corresponding author at chefess@nus.edu.sgPublished Online:30 Jun 2011https://doi.org/10.2217/nnm.11.66AboutSectionsView ArticleView Full TextPDF/EPUB ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareShare onFacebookTwitterLinkedInRedditEmail View articleKeywords: biodegradable polymerscancer nanotechnologydrug formulationdrug targetingoral chemotherapyBibliography1 Feng SS: New-concept chemotherapy by nanoparticles of biodegradable polymers –where are we now? Nanomedicine (Lond.)1(3),297–309 (2006).Link, CAS, Google Scholar2 Cao N, Feng SS: Doxorubicin conjugated to D-α-tocopheryl polyethylene glycol 1000 succinate (TPGS): in vitro cytotoxicity, in vivo pharmacokinetics and biodistribution. Biomaterials29(28),3856–3865 (2008).Crossref, Medline, CAS, Google Scholar3 Vanangamudi A, Cao N, Feng SS: Targeted delivery of doxorubicin conjugated to folic acid and D-α-tocopheryl polyethylene glycol succinate (TPGS). J. Biomed. Mat. Res. A94A(3),730–743 (2010).Google Scholar4 Zhang ZP, Feng SS: Nanoparticles of poly(lactide)/vitamin E TPGS copolymer for cancer chemotherapy: synthesis, formulation, characterization and in vitro drug release. Biomaterials27,262–270 (2006)Crossref, Medline, Google Scholar5 Zhang ZP, Feng SS: The drug encapsulation efficiency, in vitro drug release, cellular uptake and cytotoxicity of paclitaxel-loaded poly(lactide)-tocopheryl polyethylene glycol succinate nanoparticles. Biomaterials27(21),4025–4033 (2006).Crossref, Medline, CAS, Google Scholar6 Zhang ZP, Lee SH, Gan CW, Feng SS: Pharmacokinetics, biodistribution and xenograft tumor model of PLA-TPGS nanoparticles prepared by dialysis method for controlled and sustained small molecule chemotherapy. Pharmaceutical Res.25(8),1925–1935 (2008).Crossref, Medline, Google Scholar7 Gan CW, Chien S, Feng SS: Enhancement of chemotherapeutical efficacy of docetaxel by using a biodegradable nanoparticle formulation. Curr. Pharm. Design16(21),2308–2320 (2010).Crossref, Medline, CAS, Google Scholar8 Zhang ZP, Lee SH, Feng SS: Folate-decorated poly(lactide-co-glycolide)–vitamin E TPGS nanoparticles for targeted drug delivery. Biomaterials28,1889–1899 (2007).Crossref, Medline, Google Scholar9 Pan J, Feng SS: Targeted delivery of paclitaxel using folate-decorated poly(lactide) vitamin E TPGS nanoparticles. Biomaterials29,2663–2672 (2008).Crossref, Medline, CAS, Google Scholar10 Sun BF, Feng SS: Trastuzumab-functionalized nanoparticles of biodegradable copolymers for targeted delivery of Docetaxel. Nanomedicine (Lond.)4(4),431–445 (2009).Link, CAS, Google Scholar11 Feng SS, Mei L, Anitha P et al.: Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of docetaxel. Biomaterials30,3297–3306 (2009).Crossref, Medline, CAS, Google Scholar12 Pan J, Liu YT, Feng SS: Multifunctional nanoparticles of biodegradable copolymer blend for cancer diagnosis and treatment. Nanomedicine (Lond.)5(3),347–360 (2010).Link, CAS, Google Scholar13 Tan YF, Chandrasekharan P, Maity D et al.: Multimodal tumor imaging by iron oxides (IOs) and quantum dots (QDs) formulated in poly(lactic acid)-D-α-tocopheryl polyethylene glycol 1000 succinate (PLA-TPGS) nanoparticles. Biomaterials32(11),2969–2978 (2010).Crossref, Google Scholar14 Gu F, Zhang L, Teply BA et al.: Precise engineering of targeted nanoparticles by using self-assembled biointegrated block copolymers. Proc. Natl Acad. Sci. USA105,2586–2591 (2008).Crossref, Medline, CAS, Google Scholar15 Liu YT, Li K, Liu B et al.: A strategy for precision engineering of nanoparticles of biodegradable copolymers for quantitative control of targeted drug delivery. Biomaterials31,9145–9155 (2010).Crossref, Medline, CAS, Google ScholarFiguresReferencesRelatedDetailsCited ByNanomedicine strategies for sustained, controlled and targeted treatment of cancer stem cellsJie Gao, Wei Li, Yajun Guo & Si-Shen Feng17 November 2016 | Nanomedicine, Vol. 11, No. 24Nanotechnology for multimodality treatment of cancer26 October 2016 | Oncology Letters, Vol. 12, No. 6Radiosensitization of TPGS-emulsified docetaxel-loaded poly(lactic-co-glycolic acid) nanoparticles in CNE-1 and A549 cells24 November 2015 | Journal of Biomaterials Applications, Vol. 30, No. 8Vitamin E TPGS as a Molecular Biomaterial for Drug Delivery15 January 2014Chitosan- g -TPGS Nanoparticles for Anticancer Drug Delivery and Overcoming Multidrug Resistance21 November 2013 | Molecular Pharmaceutics, Vol. 11, No. 1The anticancer efficacy of paclitaxel liposomes modified with mitochondrial targeting conjugate in resistant lung cancerBiomaterials, Vol. 34, No. 14Paclitaxel drug delivery systems6 January 2013 | Expert Opinion on Drug Delivery, Vol. 10, No. 3Apoptosis induced by paclitaxel-loaded copolymer PLA–TPGS in Hep-G2 cells5 October 2012 | Advances in Natural Sciences: Nanoscience and Nanotechnology, Vol. 3, No. 4Vitamin E D-α-tocopheryl polyethylene glycol 1000 succinate-based nanomedicineZhiping Zhang, Lin Mei & Si-Shen Feng4 December 2012 | Nanomedicine, Vol. 7, No. 11Multimodality treatment of cancer with herceptin conjugated, thermomagnetic iron oxides and docetaxel loaded nanoparticles of biodegradable polymersBiomaterials, Vol. 33, No. 30Vitamin E TPGS as a molecular biomaterial for drug deliveryBiomaterials, Vol. 33, No. 19Quantitative control of targeting effect of anticancer drugs formulated by ligand-conjugated nanoparticles of biodegradable copolymer blendBiomaterials, Vol. 33, No. 6 Vol. 6, No. 4 STAY CONNECTED Metrics Downloaded 462 times History Published online 30 June 2011 Published in print June 2011 Information© Future Medicine LtdKeywordsbiodegradable polymerscancer nanotechnologydrug formulationdrug targetingoral chemotherapyFinancial & competing interests disclosureThis work is supported by: the 7th Singapore–China Cooperative Research Project Call between Agency of Science, Technology and Research (A*STAR), Singapore and The Ministry of Science and Technology (MOST), China; and the Innovation Fund of HUST (2010QN030) and the Important National Science & Technology Specific Projects, China (2009ZX09301–014). The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.No writing assistance was utilized in the production of this manuscript.PDF download

Celebrating Women in the Pharmaceutical Sciences.

Introducing the Molecular Pharmaceutics Virtual Special Issue on “advances in Molecular Pharmaceutical Research from Asia”

ChemInform Abstract: Synthetic Strategies to Glycosylated Nitrogen‐Containing Heterocyclic Compounds with Potential Anticancer Activities

Beyond the Great Wall: Recent Advances in Molecular Pharmaceutics Research in China

Translational Research: Bridging the Gap Between Fundamental Research and the Clinic

Simplifying Submission Requirements for the Journal of Medicinal Chemistry

Antibody-Based Imaging and Therapy for Precision Medicine

Chemoselective Methods for Labeling and Modification of Peptides and Proteins

Sonotheranostics and Sonogenetics Special Issue

In This Issue, Volume 14, Issue 12

Drug Design: Cutting Edge Approaches Edited by Darren R. Flower (edward Jenner Institute for Vaccine Research). Special Publication 279. Royal Society of Chemistry, Cambridge (UK). 2002. X + 192 Pp. 6 × 9.5 In. $59.50. ISBN 0-85404-816-2.

Keeping Nanomedicine on Target

Exploring the Knowledge Gaps in Infant Drug Exposure from Human Milk: A Clinical Pharmacology Perspective

In This Issue, Volume 10, Issue 8

Correction to “A Carrier-Free Nanomedicine Enables Apoptosis-Ferroptosis Synergistic Breast Cancer Therapy by Targeting Subcellular Organelles”

An Adamantyl-Substituted Retinoid-Derived Molecule That Inhibits Cancer Cell Growth and Angiogenesis by Inducing Apoptosis and Binds to Small Heterodimer Partner Nuclear Receptor: Effects of Modifying Its Carboxylate Group on Apoptosis, Proliferation, and Protein-Tyrosine Phosphatase Activity

Correction to “identification of Tumor Specific Peptide As EpCAM Ligand and Its Potential Diagnostic and Therapeutic Clinical Application”

RGD-modified PEG-PAMAM-DOX Conjugate: in Vitro and in Vivo Targeting to Both Tumor Neovascular Endothelial Cells and Tumor Cells.

Copolymer Technology for Advanced Nanomedicine

Correction to Discovery of Chromane-6-Sulfonamide Derivative as a Potent, Selective, and Orally Available Novel Retinoic Acid Receptor-Related Orphan Receptor γt Inverse Agonist.